Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 33,902 | 32,728 | 29,591 | 23,336 | 26,436 |
| Operating Income | -33,902 | -32,728 | -29,591 | -23,336 | -26,436 |
| Other Income | 897 | 1,048 | 610 | 196 | 19 |
| Pre-tax Income | -33,005 | -31,680 | -28,981 | -23,140 | -26,417 |
| Net Income Continuous | -33,005 | -31,680 | -28,981 | -23,140 | -26,417 |
| Net Income | $-33,005 | $-31,680 | $-28,981 | $-23,140 | $-26,417 |
| EPS Basic Total Ops | -10,255.59 | 6,174.12 | -13,546.33 | -24,408.95 | -32,148.56 |
| EPS Basic Continuous Ops | -10,269.01 | 5,948.63 | -13,530.57 | -20,623.69 | -32,076.38 |
| EPS Diluted Total Ops | -10,255.59 | 6,174.12 | -13,546.33 | -24,408.95 | -32,148.56 |
| EPS Diluted Continuous Ops | -10,269.01 | 5,948.63 | -13,530.57 | -20,623.69 | -32,076.38 |
| EBITDA(a) | $-33,009 | $-31,892 | $-29,339 | $-23,234 | $-26,373 |